![]() |
Volumn 19, Issue 20, 2001, Pages 4014-4022
|
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: Results of Cancer and Leukemia Group B Study 9251
a
a
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
CYTARABINE;
DEXAMETHASONE;
DOXORUBICIN;
ETOPOSIDE;
HYDROCORTISONE;
IFOSFAMIDE;
METHOTREXATE;
PREDNISONE;
VINCRISTINE;
ACUTE LYMPHOCYTIC LEUKEMIA;
ADULT;
AGED;
ARTICLE;
BLOOD TOXICITY;
BRAIN RADIATION;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
DRUG MEGADOSE;
FEMALE;
HUMAN;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
MYELITIS;
NEUROTOXICITY;
NONHODGKIN LYMPHOMA;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
|
EID: 0035886710
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2001.19.20.4014 Document Type: Article |
Times cited : (78)
|
References (16)
|